ArticleTranslational cancer research2025

Transarterial chemoembolization in combination with lenvatinib and sintilimab for the treatment of unresectable hepatocellular carcinoma with arterioportal shunts: a retrospective analysis.

Hui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.